+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

COPD classification models and mortality prediction capacity

COPD classification models and mortality prediction capacity

International Journal of Chronic Obstructive Pulmonary Disease 14: 605-613

Our aim was to assess the impact of comorbidities on existing COPD prognosis scores. A total of 543 patients with COPD (FEV1 <80% and FEV1/FVC <70%) were included between January 2003 and January 2004. Patients were stable for at least 6 weeks before inclusion and were followed for 5 years without any intervention by the research team. Comorbidities and causes of death were established from medical reports or information from primary care medical records. The GOLD system and the body mass index, obstruction, dyspnea and exercise (BODE) index were used for COPD classification. Patients were also classified into four clusters depending on the respiratory disease and comorbidities. Cluster analysis was performed by combining multiple correspondence analyses and automatic classification. Receiver operating characteristic curves and the area under the curve (AUC) were calculated for each model, and the DeLong test was used to evaluate differences between AUCs. Improvement in prediction ability was analyzed by the DeLong test, category-free net reclassification improvement and the integrated discrimination index. Among the 543 patients enrolled, 521 (96%) were male, with a mean age of 68 years, mean body mass index 28.3 and mean FEV1% 55%. A total of 167 patients died during the study follow-up. Comorbidities were prevalent in our cohort, with a mean Charlson index of 2.4. The most prevalent comorbidities were hypertension, diabetes mellitus and cardiovascular diseases. On comparing the BODE index, GOLDABCD, GOLD2017 and cluster analysis for predicting mortality, cluster system was found to be superior compared with GOLD2017 (0.654 vs 0.722, P=0.006), without significant differences between other classification models. When cardiovascular comorbidities and chronic renal failure were added to the existing scores, their prognostic capacity was statistically superior (P<0.001). Comorbidities should be taken into account in COPD management scores due to their prevalence and impact on mortality.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 066598258

Download citation: RISBibTeXText

PMID: 30880950

DOI: 10.2147/copd.s184695

Related references

Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio. International Journal of Chronic Obstructive Pulmonary Disease 13: 1105-1113, 2018

An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD. Respiratory Care 57(9): 1452-1459, 2012

Drawing impairment predicts mortality in severe COPD: a naive approach to COPD mortality prediction. Chest 132(4): 1411; Author Reply 1411-2, 2007

Prognostic Accuracy of Three COPD Classification Systems in Relation to Long-Term Mortality of COPD Patients: A Prospective Multicenter Study. Lung 197(2): 173-179, 2019

Mortality prediction models in intensive care: acute physiology and chronic health evaluation II and mortality prediction model compared. Critical Care Medicine 19(2): 191-197, 1991

Causes of death and prediction of mortality in COPD. Archivos de Bronconeumologia 46(7): 343-346, 2010

Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort. Journal of the National Medical Association 111(1): 94, 2019

Adrenomedullin optimises mortality prediction in COPD patients. Respiratory Medicine 109(6): 734-742, 2015

Prediction and prevention of exacerbations and mortality in patients with COPD. Expert Review of Respiratory Medicine 10(7): 739-753, 2016

Prediction models for exacerbations in patients with COPD. European Respiratory Review 26(143):, 2017

Prediction of mortality in very premature infants: a systematic review of prediction models. Plos one 6(9): E23441, 2011

Mortality risk prediction in COPD by a prognostic biomarker panel. European Respiratory Journal 44(6): 1557-1570, 2014

Inflammatory biomarkers improve the clinical prediction of mortality in COPD. 2012

Prediction models for the development of COPD: a systematic review. International Journal of Chronic Obstructive Pulmonary Disease 13: 1927-1935, 2018

COPD classification methods and informativeness on mortality: contrasting evidences. Minerva Medica 104(6 Suppl 1): 1-5, 2013